Nevertheless, there is a substantial body of data describing the importance of heparanase, Sulf1, and Sulf2 in modulating HS functioning in cancer, which highlights the already well founded view that targeting the ability of tumors to modify their microenvironment in order to promote growth and spread represents a solid therapeutic development pathway. The gene discussed is SULF1; the disease is cancer.